Stabilization of Protein Protein Interactions; transforming molecular glue disco...
Stabilization of Protein Protein Interactions; transforming molecular glue discovery from art into science
Intrinsically Disordered Proteins (IDPs) represent one of drug discovery’s major challenges. Due to their high degree of conformational freedom, IDPs have no defined pockets for binding small molecules. Molecular glues that can st...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
IDP Assembly
Novel Integrated Approach for Assembly Analysis of Intrinsic...
215K€
Cerrado
PGC2018-099321-B-I00
SIMULACION POR ORDENADOR DEL PAPEL DE LOS METALES EN LA AGRE...
88K€
Cerrado
IDP2Biomed
Bringing Intrinsically Disordered Proteins to Biomedical App...
1M€
Cerrado
PID2021-127907NB-I00
FUERZAS MOLECULARES EN PROTEINAS INTRINSECAMENTE DESORDENADA...
139K€
Cerrado
BFU2015-67284-R
HERRAMIENTAS PARA EL ESTUDIO DE INTERACCIONES PROTEINA-PROTE...
121K€
Cerrado
UNDERPIN
Untranslated regions of RNAs and protein networks in patholo...
173K€
Cerrado
Información proyecto PPI-Glue
Duración del proyecto: 63 meses
Fecha Inicio: 2023-05-24
Fecha Fin: 2028-08-31
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
Intrinsically Disordered Proteins (IDPs) represent one of drug discovery’s major challenges. Due to their high degree of conformational freedom, IDPs have no defined pockets for binding small molecules. Molecular glues that can strengthen protein-protein interactions (PPIs) are a revolutionary technology for drug discovery. The hub protein 14-3-3 regulates many IDPs via phosphorylation-dependent PPIs. Stabilization of 14-3-3 PPIs with small molecular glues provides a unique entry point to render IDPs druggable and mitigate the aberrant behaviour of malfunctioning IDPs, for example in neurodegenerative diseases.
While inhibition of PPIs by small molecules has expanded the proteome suitable for therapeutic intervention, the opposite chemical-biology strategy of PPI stabilization by small molecular glues is, despite a recent surge of interest, remarkably underexplored. The lack of mechanistically understanding PPI stabilization impedes systematically identifying molecular glues and limits progress to drug IDPs. Based on compelling preliminary data, I propose here that mechanistic understanding of 14-3-3 PPI stabilization will play a crucial role in the discovery of molecular glues for IDPs and transform molecular glue drug discovery from art into science.
We will tackle this central question by pursuing two key objectives: Objective 1 – Mechanistically understand PPI stabilization between the 14-3-3 scaffold protein and IDPs. This will address the underlying thermodynamic and kinetic processes, conformational selection, multivalency, cooperativity and selectivity; Objective 2 –Drugging the undruggable -biomolecular condensates and IDPs- via PPI stabilization approaches. The potential for PPI stabilization in the dense environments of biomolecular condensates will be uncovered and a mechanism-driven campaign to identify molecular glues for the 14-3-3/Tau PPI will lead the way to novel drug discovery for neurodegenerative diseases.